|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Insider Roundup While analyst recommendations can be a hit or miss, insider transactions are usually more telling of a company’s future stock behavior. Insiders are major owners and/or management of a ...
For the S&P 500, 2016 cannot be described as anything less than a bloodbath to this point. The market hit new 52-week lows once again on Wednesday, but incredibly there are a handful of stocks making new ...
The Zacks Analyst Blog Highlights: ALPS Medical Breakthroughs ETF, Anacor Pharmaceuticals, Dyax, Ultragenyx Pharmaceutical and ImmunoGen